Effect of C1-esterase Inhibitor on Systemic Inflammation in Trauma Patients With a Femur or Pelvic Fracture

PHASE3TerminatedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

February 28, 2015

Study Completion Date

February 28, 2015

Conditions
TraumaInflammationSepsisMultiple Organ Dysfunction Syndrome
Interventions
DRUG

C1-esterase inhibitor

C1-esterase inhibitor 200 U/kg infusion over 30 minutes, just before the start of the femur or pelvic fixation operation.

OTHER

Saline 0.9%

Infusion, just before the start of the femur or pelvic fixation operation

Trial Locations (1)

3508 GA

University Medical Centre Utrecht, Utrecht

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Prothya Biosolutions

INDUSTRY

lead

UMC Utrecht

OTHER

NCT01275976 - Effect of C1-esterase Inhibitor on Systemic Inflammation in Trauma Patients With a Femur or Pelvic Fracture | Biotech Hunter | Biotech Hunter